# | Title | Journal | Year | Citations |
---|
1 | Influence of diet on the gut microbiome and implications for human health | Journal of Translational Medicine | 2017 | 1,714 |
2 | Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey | Journal of Translational Medicine | 2020 | 1,382 |
3 | Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial | Journal of Translational Medicine | 2005 | 993 |
4 | Inflammatory mechanisms in ischemic stroke: therapeutic approaches | Journal of Translational Medicine | 2009 | 888 |
5 | A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer | Journal of Translational Medicine | 2005 | 870 |
6 | Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant | Journal of Translational Medicine | 2020 | 784 |
7 | Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages | Journal of Translational Medicine | 2011 | 757 |
8 | Cancer classification using the Immunoscore: a worldwide task force | Journal of Translational Medicine | 2012 | 676 |
9 | The immune score as a new possible approach for the classification of cancer | Journal of Translational Medicine | 2012 | 656 |
10 | Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage | Journal of Translational Medicine | 2020 | 625 |
11 | Body fluid derived exosomes as a novel template for clinical diagnostics | Journal of Translational Medicine | 2011 | 612 |
12 | The role of BRAF V600 mutation in melanoma | Journal of Translational Medicine | 2012 | 563 |
13 | Risk factors in the development of stem cell therapy | Journal of Translational Medicine | 2011 | 551 |
14 | Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis | Journal of Translational Medicine | 2015 | 533 |
15 | Tumor microenvironment differences between primary tumor and brain metastases | Journal of Translational Medicine | 2020 | 532 |
16 | A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma | Journal of Translational Medicine | 2011 | 500 |
17 | Endometrial regenerative cells: A novel stem cell population | Journal of Translational Medicine | 2007 | 496 |
18 | RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation | Journal of Translational Medicine | 2009 | 491 |
19 | LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b | Journal of Translational Medicine | 2015 | 469 |
20 | A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods | Journal of Translational Medicine | 2014 | 454 |
21 | Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis | Journal of Translational Medicine | 2014 | 436 |
22 | The role of collagen in cancer: from bench to bedside | Journal of Translational Medicine | 2019 | 436 |
23 | Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males | Journal of Translational Medicine | 2016 | 433 |
24 | Recent advances in bioprinting techniques: approaches, applications and future prospects | Journal of Translational Medicine | 2016 | 406 |
25 | The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects | Journal of Translational Medicine | 2005 | 395 |
26 | Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation | Journal of Translational Medicine | 2014 | 391 |
27 | Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma | Journal of Translational Medicine | 2018 | 391 |
28 | TGF-β – an excellent servant but a bad master | Journal of Translational Medicine | 2012 | 390 |
29 | Identification and proteomic profiling of exosomes in human cerebrospinal fluid | Journal of Translational Medicine | 2012 | 390 |
30 | Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury | Journal of Translational Medicine | 2012 | 388 |
31 | Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study | Journal of Translational Medicine | 2012 | 387 |
32 | Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment | Journal of Translational Medicine | 2006 | 378 |
33 | First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma | Journal of Translational Medicine | 2018 | 376 |
34 | Identification and manipulation of tumor associated macrophages in human cancers | Journal of Translational Medicine | 2011 | 370 |
35 | Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis | Journal of Translational Medicine | 2009 | 366 |
36 | Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance | Journal of Translational Medicine | 2013 | 359 |
37 | Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | 2020 | 353 |
38 | Nerve growth factor: from the early discoveries to the potential clinical use | Journal of Translational Medicine | 2012 | 352 |
39 | Exosome removal as a therapeutic adjuvant in cancer | Journal of Translational Medicine | 2012 | 329 |
40 | Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs | Journal of Translational Medicine | 2011 | 323 |
41 | Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy | Journal of Translational Medicine | 2014 | 321 |
42 | Regulatory mechanisms of microRNA expression | Journal of Translational Medicine | 2016 | 321 |
43 | Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins | Journal of Translational Medicine | 2007 | 297 |
44 | Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases | Journal of Translational Medicine | 2014 | 286 |
45 | Considerations in the development of circulating tumor cell technology for clinical use | Journal of Translational Medicine | 2012 | 282 |
46 | Tumour macrophages as potential targets of bisphosphonates | Journal of Translational Medicine | 2011 | 270 |
47 | Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction | Journal of Translational Medicine | 2011 | 270 |
48 | Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis | Journal of Translational Medicine | 2009 | 269 |
49 | BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs | Journal of Translational Medicine | 2012 | 268 |
50 | Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer | Journal of Translational Medicine | 2013 | 262 |